Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2014 / Cilt: 22 - Sayı: 2

Koroner arter baypas greft hastalarında statin ön tedavisi sağ atriyal miyosit apoptozisini etkiler mi? In-vivo pilot çalışma

Does statin pre-treatment affect right atrial myocyte apoptosis in coronary artery bypass graft patients? an in-vivo pilot study

Pages
327–333
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Statin pretreatment before CABG seems to diminish cardiac myocyte loss, providing an explanation for their beneficial effects seen after open heart surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: This study aims to investigate the possible protective effects of statin pretreatment against right atrial myocyte apoptosis in patients undergoing coronary artery bypass grafting.
📊
Key Findings & Data:Group 1 patients (n=12; male: 83.3%) were initiated on atorvastatin 40 mg/day on the day of hospital admission and group 2 patients (n=17; male: 82.3%) did not receive statin therapy.
💡
Conclusion & Impact:Conclusion: Statin pretreatment before CABG seems to diminish cardiac myocyte loss, providing an explanation for their beneficial effects seen after open heart surgery.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: This study aims to investigate the possible protective effects of statin pretreatment against right atrial myocyte apoptosis in patients undergoing coronary artery bypass grafting. Methods: Twenty-nine consecutive patients were included in the study. Group 1 patients (n=12; male: 83.3%) were initiated on atorvastatin 40 mg/day on the day of hospital admission and group 2 patients (n=17; male: 82.3%) did not receive statin therapy. Right atrial samples were taken before cardiopulmonary bypass and fixed in 10% neutral formalin. Immunoperoxidase staining and TUNEL method were performed to detect apoptotic cells. The immunostained active caspase-3 and proliferating cell nuclear antigen (PCNA) cells were counted using a light microscope. Results: The mean apoptotic index was significantly lower in endocardial (p=0.04) and epicardial layers (p=0.01) of group 1 patients compared to those of group 2. Myocardial layer values were similar between the groups (p=0.35). The mean PCNA index in any layers was not significantly different between groups. Conclusion: Statin pretreatment before CABG seems to diminish cardiac myocyte loss, providing an explanation for their beneficial effects seen after open heart surgery.

Özet

Amaç: Bu çalışmada koroner arter baypas greftleme yapılan hastalarda statin ön tedavisinin sağ atriyal miyositlerin apoptozisine karşı olası koruyucu etkileri araştırıldı.Ça­lış­ma­ pla­nı:­ Çalışmaya 29 ardışık hasta dahil edildi. Grup 1'deki hastalara (n=12; erkek: 83.3%) hastaneye yatış gününden itibaren atorvastatin 40 mg/gün tedavisi uygulandı, grup 2'deki hastalara (n=17; erkek: 82.3%) ise statin tedavisi uygulanmadı. Sağ atriyal örnekler kardiyopulmoner baypasa girilmeden önce alındı ve %10'luk nötral formalin ile fikse edildi. Apoptotik hücrelerin tespiti için immünoperoksidaz boyama ve TUNEL yöntemi kullanıldı. Immün boyamalı aktif kaspas-3 ve proliferatif hücre nükleer antijen (PCNA) hücrelerinin sayımı ışık mikroskopu kullanılarak yapıldı.Bul gu lar: Grup 1'deki hastaların endokardiyal (p=0.04) ve epikardiyal (p=0.01) katmanlarındaki ortalama apoptotik indeks değerleri grup 2'dekilere kıyasla, anlamlı düzeyde düşük bulundu. Miyokardiyal katmanlardaki değerler arasında fark olmadığı görüldü (p=0.35). Katmanlar arasında ortalama PCNA indeksi açısından anlamlı fark yoktu.So nuç: Koroner arter baypas greftleme öncesi statin ön tedavisinin kardiyak miyosit kaybını azaltabileceği görünmekte olup, açık kalp cerrahisi sonrası yararlı etkilere işaret edebilir.

🔖

Cite This Article

ÖZTURK, M., SEZGİN, G., KIRALİ, K., SARIKAYA, S., BÜYÜKBAYRAK, F., DAĞISTANLI, F. K., ALP, M., AKSOY, E. (2022). Koroner arter baypas greft hastalarında statin ön tedavisi sağ atriyal miyosit apoptozisini etkiler mi? In-vivo pilot çalışma. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 22 - Sayı: 2, 327–333. https://ajindex.com/articles/424291

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
  2. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-41.
  3. Sadoshima J, Montagne O, Wang Q, Yang G, Warden J, Liu J, et al. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J Clin Invest 2002;110:271-9.
  4. Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2012;143:4-34.
  5. Liakopoulos OJ, Kuhn EW, Slottosch I, Wassmer G, Wahlers T. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev 2012;4:CD008493. Rodrigo R. Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system. Front Physiol 2012;3:93. Stoppe C, Werker T, Rossaint R, Dollo F, Lue H, Wonisch W, et al. What is the significance of perioperative release of macrophage migration inhibitory factor in cardiac surgery? Antioxid Redox Signal 2013;19:231-9.
  6. Crow MT, Mani K, Nam YJ, Kitsis RN. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 2004;95:957-70.
  7. Hausenloy DJ, Ong SB, Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 2009;104:189-202.
  8. Lemoine S, Allouche S, Coulbault L, Cornet V, Massetti M, Galera P, et al. Mechanisms involved in cardioprotective effects of pravastatin administered during reoxygenation in human myocardium in vitro. Anesthesiology 2012;116:824-33.
  9. Demyanets S, Kaun C, Pfaffenberger S, Hohensinner PJ, Rega G, Pammer J, et al. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro. Biochem Pharmacol 2006;71:1324-30.
  10. Deniz GC, Durdu S, Akar AR, Akyürek N, Akyürek O, Zaim C, et al. Apoptotic protein expressions in human right atrial myocytes with permanent fibrillation. Turk Gogus Kalp Dama 2010;18:106-14.
  11. Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004;110:II45-9. Elahi MM, Flatman S, Matata BM. Tracing the origi